TRENTINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 6.596
EU - Europa 2.349
AS - Asia 1.733
SA - Sud America 77
OC - Oceania 13
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.787
Nazione #
US - Stati Uniti d'America 6.550
IT - Italia 736
CN - Cina 682
SG - Singapore 555
PL - Polonia 435
DE - Germania 288
UA - Ucraina 246
TR - Turchia 213
GB - Regno Unito 176
FI - Finlandia 103
ID - Indonesia 98
SE - Svezia 87
BR - Brasile 68
HK - Hong Kong 61
BE - Belgio 44
IE - Irlanda 43
CA - Canada 41
CZ - Repubblica Ceca 29
FR - Francia 28
VN - Vietnam 28
NL - Olanda 27
AT - Austria 24
IR - Iran 17
ES - Italia 16
KR - Corea 16
RU - Federazione Russa 15
IN - India 13
TW - Taiwan 13
LT - Lituania 12
AU - Australia 10
RO - Romania 9
BG - Bulgaria 7
IQ - Iraq 7
JP - Giappone 7
MY - Malesia 7
SD - Sudan 7
PT - Portogallo 5
EU - Europa 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
EG - Egitto 3
HR - Croazia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
UZ - Uzbekistan 3
AL - Albania 2
AR - Argentina 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
MX - Messico 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 10.787
Città #
Fairfield 776
Woodbridge 701
Ann Arbor 492
Santa Clara 467
Chandler 452
Ashburn 433
Warsaw 419
Houston 412
Singapore 358
Ferrara 318
Jacksonville 316
Seattle 277
Wilmington 260
Cambridge 251
Izmir 156
Beijing 127
Nanjing 121
Princeton 115
Menlo Park 98
Jakarta 91
Shanghai 82
Boardman 75
Milan 75
Bologna 56
Hong Kong 56
Dearborn 55
San Diego 52
Addison 48
Brussels 42
Nanchang 40
Shenyang 40
Helsinki 39
Los Angeles 38
Bremen 37
New York 34
Munich 30
London 28
Dong Ket 27
Falls Church 26
Changsha 25
Brno 24
Tianjin 24
Jiaxing 21
Falkenstein 20
Nuremberg 20
Toronto 20
Hebei 18
Redwood City 18
Norwalk 16
Ningbo 15
Orange 15
St Louis 15
Vienna 15
Washington 14
Frankfurt am Main 13
Guangzhou 12
Jinan 12
Mountain View 12
Auburn Hills 10
Augusta 10
Ottawa 10
Rome 10
Hefei 9
Kraków 9
Casalecchio Di Reno 8
Chicago 8
Des Moines 8
Leawood 8
Montréal 8
San Mateo 8
Indiana 7
Taizhou 7
Zhengzhou 7
Ferrara di Monte Baldo 6
Kunming 6
São Paulo 6
Taipei 6
Tappahannock 6
Cagliari 5
Dublin 5
Kilburn 5
Lübeck 5
Marigliano 5
Modena 5
Wageningen 5
Clifton 4
Council Bluffs 4
Fort Worth 4
Haikou 4
Khartoum 4
Lanzhou 4
Lappeenranta 4
Madison 4
Melbourne 4
Monmouth Junction 4
Padova 4
Palermo 4
Parma 4
Philadelphia 4
Shah Alam 4
Totale 8.101
Nome #
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 233
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 196
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 187
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 181
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 170
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 169
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 165
null 163
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 159
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 152
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 151
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 151
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 149
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 145
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 145
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 139
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 138
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 135
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 134
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 132
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 132
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 129
null 128
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 127
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 127
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 125
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 122
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 121
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 120
Leptin/adiponectin ratio predicts post-stroke neurological outcome 120
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 117
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 116
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 115
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 114
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 112
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 112
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 111
null 110
null 106
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 106
Evaluation of a possible role of oxidative stress in climacteric symptoms. 105
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 104
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 102
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 102
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 101
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 99
null 97
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 96
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 96
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 95
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 93
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 92
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 92
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 92
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 92
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 91
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 91
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 91
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 88
null 86
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 85
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 85
null 85
null 83
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 79
null 78
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 77
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 75
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 75
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 72
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 69
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 68
null 68
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 68
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 67
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 66
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 66
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 65
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 64
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 63
Purification of transglutaminase enzyme from L. infantum promastigotes 63
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 62
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 61
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 60
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 60
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 59
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 57
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 56
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 54
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 53
MMP-9 isoforms in serum of Multiple Sclerosis patients 51
The influence of different replacement solutions on neutrophils response 51
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 49
null 49
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 49
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 48
Paraoxonase-1 and dementia-related diseases 45
null 44
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 44
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 44
Totale 9.986
Categoria #
all - tutte 62.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020506 0 0 0 0 0 0 0 0 189 171 86 60
2020/20211.782 106 110 94 154 162 164 102 185 89 310 181 125
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20251.837 106 98 292 148 442 330 146 211 64 0 0 0
Totale 11.171